Paratek Pharmaceuticals, Inc.
PRTKNASDAQHealthcare
$2.23
+$0.04(+1.83%)
Market Cap$127828952
P/E Ratio—
52W High$3.65
52W Low$1.29
Paratek Pharmaceuticals, Inc. (PRTK) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
PRTK · earnings · updated Jun 9, 2026
Latest Earnings
Q4 FY2023Report Date: Nov 2, 2023EPS Actual
-$0.38
Est. -$0.25 · -52.0%
Revenue
—
Est. $0.04B
Fiscal Period
Q4 FY2023
FY ends December
Report Date
Nov 2, 2023
After Market Close
▼ Miss EPS
PRTK reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2024 | Aug 1, 2024 | — | — | — | — | — | — |
| ◌ Q2 FY2024 | May 7, 2024 | — | — | — | — | — | — |
| ◌ Q1 FY2024 | Mar 14, 2024 | — | — | — | — | — | — |
| ▼ Q4 FY2023 | Nov 2, 2023 | -$0.25 | -$0.38 | -52.0% | — | $0.04B | — |
| ▼ Q3 FY2023 | Aug 3, 2023 | $0.31 | $0.25 | -19.4% | $0.04B | $0.03B | +12.4% |
| ▼ Q2 FY2023 | May 9, 2023 | $0.38 | $0.35 | -7.9% | $0.03B | $0.03B | -7.6% |
| ▲ Q1 FY2023 | Mar 16, 2023 | $0.04 | $0.12 | +228.6% | $0.07B | $0.06B | +14.5% |
| ▲ Q4 FY2022 | Nov 3, 2022 | $0.27 | $0.38 | +40.7% | $0.03B | — | — |
Q3 FY2024
Aug 1, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2024
May 7, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2024
Mar 14, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2023
Nov 2, 2023Miss
EPS Actual
-$0.38
EPS Est.
-$0.25
EPS Surpr.
-52.0%
Revenue
—
Q3 FY2023
Aug 3, 2023Miss
EPS Actual
$0.25
EPS Est.
$0.31
EPS Surpr.
-19.4%
Revenue
$0.04B
Q2 FY2023
May 9, 2023Miss
EPS Actual
$0.35
EPS Est.
$0.38
EPS Surpr.
-7.9%
Revenue
$0.03B
Q1 FY2023
Mar 16, 2023Beat
EPS Actual
$0.12
EPS Est.
$0.04
EPS Surpr.
+228.6%
Revenue
$0.07B
Q4 FY2022
Nov 3, 2022Beat
EPS Actual
$0.38
EPS Est.
$0.27
EPS Surpr.
+40.7%
Revenue
$0.03B
No analyst estimates available for PRTK.
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q4 FY2023 | Nov 2, 2023 | -52.0% | $2.23 | — | — |
| ▼ Q3 FY2023 | Aug 3, 2023 | -19.4% | $2.22 | $2.20 | -0.90% |
| ▼ Q2 FY2023 | May 9, 2023 | -7.9% | $1.80 | $1.69 | -6.11% |
| ▲ Q1 FY2023 | Mar 16, 2023 | +228.6% | $1.91 | $1.48 | -22.51% |
| ▲ Q4 FY2022 | Nov 3, 2022 | +40.7% | $3.35 | $3.42 | +2.09% |
| ▼ Q3 FY2022 | Aug 3, 2022 | -5.7% | $2.43 | $2.52 | +3.70% |
| ▲ Q2 FY2022 | May 4, 2022 | +0.0% | $2.18 | $2.18 | +0.00% |
| ▲ Q1 FY2022 | Mar 14, 2022 | +256.1% | $3.48 | $3.23 | -7.33% |
Q4 FY2023—
Report Date
Nov 2, 2023
EPS Beat/Miss
-52.0%
Price Before
$2.23
Price After
—
Q3 FY2023-0.90%
Report Date
Aug 3, 2023
EPS Beat/Miss
-19.4%
Price Before
$2.22
Price After
$2.20
Q2 FY2023-6.11%
Report Date
May 9, 2023
EPS Beat/Miss
-7.9%
Price Before
$1.80
Price After
$1.69
Q1 FY2023-22.51%
Report Date
Mar 16, 2023
EPS Beat/Miss
+228.6%
Price Before
$1.91
Price After
$1.48
Q4 FY2022+2.09%
Report Date
Nov 3, 2022
EPS Beat/Miss
+40.7%
Price Before
$3.35
Price After
$3.42
Q3 FY2022+3.70%
Report Date
Aug 3, 2022
EPS Beat/Miss
-5.7%
Price Before
$2.43
Price After
$2.52
Q2 FY2022+0.00%
Report Date
May 4, 2022
EPS Beat/Miss
+0.0%
Price Before
$2.18
Price After
$2.18
Q1 FY2022-7.33%
Report Date
Mar 14, 2022
EPS Beat/Miss
+256.1%
Price Before
$3.48
Price After
$3.23
Avg Beat Reaction-6.94%
Avg Miss Reaction-1.10%
Beat Rate4 / 8 quarters
Largest Move-22.51% (Q1 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: PRTK ends December
Paratek Pharmaceuticals, Inc. (PRTK) most recently reported earnings on November 2, 2023 for Q4 FY2023, posting EPS of $-0.38 — missing the analyst consensus of $-0.25 by -52.0%. The next PRTK earnings date is expected around September 1, 2026.
Each quarter, investors track PRTK earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. PRTK revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
PRTK's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
PRTK earnings · 5 questionsParatek Pharmaceuticals, Inc.'s next earnings report is expected around September 1, 2026. PRTK typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; PRTK historically reports after market close (AMC).
PRTK earnings datewhen is PRTK earningsPRTK next earnings datewhen does PRTK report earningsPRTK earnings calendar
▸ Source: FMP · Paratek Pharmaceuticals, Inc. SEC filings · US GAAP · Paratek Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026